Cargando…
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding was observed from the upper respiratory tract of a female immunocompromised individual with chronic lymphocytic leukemia and acquired hypogammaglobulinemia. Shedding of infectious SARS-CoV-2 was observed up to 70 days, a...
Autores principales: | Avanzato, Victoria A., Matson, M. Jeremiah, Seifert, Stephanie N., Pryce, Rhys, Williamson, Brandi N., Anzick, Sarah L., Barbian, Kent, Judson, Seth D., Fischer, Elizabeth R., Martens, Craig, Bowden, Thomas A., de Wit, Emmie, Riedo, Francis X., Munster, Vincent J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640888/ https://www.ncbi.nlm.nih.gov/pubmed/33248470 http://dx.doi.org/10.1016/j.cell.2020.10.049 |
Ejemplares similares
-
Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
por: Prescott, Joseph, et al.
Publicado: (2018) -
Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2
por: Munster, Vincent J., et al.
Publicado: (2020) -
Assessment of N95 respirator decontamination and re-use for SARS-CoV-2
por: Fischer, Robert J., et al.
Publicado: (2020) -
Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus
por: Fischer, Robert J., et al.
Publicado: (2020) -
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
por: Fischer, Robert J., et al.
Publicado: (2021)